department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Chugai Pharmaceutical Co Ltd · pharmadog

PUBLIC COMPANY

Chugai Pharmaceutical Co Ltd

updated 1mo ago

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 11Phase 2

Acquired Hemophilia A

Coagulation factor IX and X

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 completion (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Chugai Pharmaceutical Co Ltd jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

phase 1 completion

Chugai Pharmaceutical Co Ltd — tocilizumab (Phase I Trial Completion)

Active trials

phase1AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancernot yet recruitingn=102
phase2Study of DONQ52 in Active Celiac Diseaserecruitingn=92
phase1Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)recruitingn=144
phase1Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)enrolling by invitationn=144
phase1A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumorscompletedn=22
phase1Study of AUBE00 in Patients With Solid Tumorsrecruitingn=130
phase1A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCERrecruitingn=122
phase1A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).terminatedn=128

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

tagOncology1 co-mentions · 1 sources
tagDLBCL1 co-mentions · 1 sources
drugtocilizumab1 co-mentions · 1 sources
drugACTEMRA1 co-mentions · 1 sources